Glycosaminoglycans are a potential cause of rheumatoid arthritis.
about
Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune responseEffect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation.Glycosaminoglycans detection methods: Applications of mass spectrometry.Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosisAdenovirus-mediated gene transfer of mutated IkappaB kinase and IkappaBalpha reveal NF-kappaB-dependent as well as NF-kappaB-independent pathways of HAS1 activation.Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunityApoptosis-like cell death induction and aberrant fibroblast properties in human incisional hernia fascia.UP3005, a Botanical Composition Containing Two Standardized Extracts of Uncaria gambir and Morus alba, Improves Pain Sensitivity and Cartilage Degradations in Monosodium Iodoacetate-Induced Rat OA Disease Model.Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin MMechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis.Using Small-Angle Scattering Techniques to Understand Mechanical Properties of Biopolymer-Based Biomaterials.Anti-inflammatory Effect of Isaria sinclairii Glycosaminoglycan in an Adjuvant-treated Arthritis Rat Model.Anti-inflammatory effect of glycosaminoglycan derived from Gryllus bimaculatus (a type of cricket, insect) on adjuvant-treated chronic arthritis rat model.The anti-rheumatic gold salt aurothiomalate suppresses interleukin-1beta-induced hyaluronan accumulation by blocking HAS1 transcription and by acting as a COX-2 transcriptional repressor.Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints.Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation.Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses.Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways.Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.Raman spectroscopy and regenerative medicine: a review.
P2860
Q24803951-56353F2A-B340-46D0-A495-08C5EDD8CD7FQ30495848-E86C838C-766C-4880-BDF2-DA80E3689BCCQ33769317-7766D7CC-7775-4116-91E7-A5FFC57E1087Q33816146-D1DC8FCD-B47A-41F0-9C0E-64414423DF29Q34069452-1102825D-7495-4576-B6FA-D6829EFBCE1EQ34463886-AD813CA3-0C0B-4DFF-BA9D-1F6135BDD4E6Q34839450-4204231C-8A3B-4D3D-B194-59B83DFDBB6EQ35070641-1B06956B-8769-4445-9209-4B90CA0AFC6EQ35159282-F7E95A96-1C9E-4A3C-B4F9-CE9EA61D10CAQ35209487-084C11D7-2006-4E09-8396-559757003602Q35622999-980EBE60-9C30-4430-A908-D62435F372B9Q36072816-CCF9002E-0E64-46B7-9D7A-D6EADCB7B10FQ36357390-5D1D57AC-9F66-42D4-939C-BC5F47B15E1BQ36993245-004F535B-16F4-4F74-9758-E3E97016AB7DQ37329057-F035D6F3-72DB-4B95-A209-CA235259A354Q37425236-AA30F71D-0D24-4C95-91EC-530EBC6C125FQ38945364-1F397C47-F054-44A3-ADDF-D5B0295E3D2DQ40211884-1AC5CEB1-FB61-473C-8D4B-7CF56CEBB45AQ42644114-A91C7BD8-4866-460C-9BE1-8C00A7C69DDBQ44693918-A2A00430-CC7C-4CA6-904C-1B233989AA8DQ46641420-EF38197E-2559-4BCB-BF4E-018A32D6E890Q47307649-63ABC5DC-98FC-4577-BF35-D28D9C34EFD2Q47555734-548E7419-DD50-48D5-BD12-E1FA34DBB2E7Q52729643-3E00048B-CC90-4FEF-853E-3DF748ED75EA
P2860
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@ast
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@en
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@nl
type
label
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@ast
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@en
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@nl
prefLabel
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@ast
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@en
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@nl
P2860
P356
P1476
Glycosaminoglycans are a potential cause of rheumatoid arthritis.
@en
P2093
Julia Y Wang
Michael H Roehrl
P2860
P304
14362-14367
P356
10.1073/PNAS.222536599
P407
P577
2002-10-21T00:00:00Z